JOURNAL OF BUON, vol.22, no.4, pp.863-868, 2017 (Journal Indexed in SCI)
Article / Article
Title of Journal :
JOURNAL OF BUON
Purpose: To evaluate the efficacy and adverse events with cetuximab plus FOLFOX administered as second- and third-line therapy in metastatic colorectal cancer (mCRC) patients.